Sort
82,697 grants matching “vaccine development”
HIV Preventive Vaccine and Monoclonal Antibody Studies
$6,244,013Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
$6,237,659Paul Glyndwr Thomas · St. Jude Children'S Research Hospital · U01 · FY2024 · AI
The Michigan Infectious Disease Genomics (MIDGE) Center
$6,233,451Adam Lauring · University Of Michigan At Ann Arbor · U19 · FY2024 · AI
ATN Coordinating Center
$6,221,851Craig M Wilson · University Of Alabama At Birmingham · U01 · FY2007 · HD
Medicinal chemistry core
$6,211,475Adam R Renslo · University Of California, San Francisco · U19 · FY2022 · AI
Development and Production of HIV Vaccines and Adjuvants
$6,197,003Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2020 · AI
Core B - Facility Maintenance and Operation Core
$6,194,524Thomas Gary Ksiazek · University Of Texas Med Br Galveston · UC7 · FY2025 · AI
KARABELO Clinical Trials Unit for NIAID Networks
$6,186,290Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2020 · AI
Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages
$6,183,078Barton F Haynes · Duke University · U19 · FY2022 · AI
Development of Mutivalent Filovirus (Ebola and Marburg) Vaccines
$6,180,074Javad Aman · Integrated Biotherapeutics, Inc. · N01 · FY2009 · AI
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of mRNA, Lipid Nanoparticle Based HIV Immunogens
$6,174,301Wendell Beres · Duke University · N01 · FY2023 · AI
Center for Research in Diagnostics and Discovery
$6,171,847W. Ian Lipkin · Columbia University Health Sciences · U19 · FY2018 · AI
Task 13/C26 Challenge Models and Assays to Develop Influenza Vaccines
$6,158,997Judy Britt · Southern Research Institute · N01 · FY2009 · AI
SURGERY IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER
$6,155,521John Wayne Cancer Institute · P01 · FY2000 · CA
Task V11: General Safety Toxicity Testing, SARS-CoV-2
$6,134,108Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2024 · AI
UCSF HIV Clinical Trials Unit
$6,132,107Diane V Havlir · University Of California, San Francisco · UM1 · FY2012 · AI
Adjuvant development in the context of seasonal and pandemic influenza
$6,116,145University Of Montana · N01 · FY2018 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$6,113,687David S Stephens · Emory University · UM1 · FY2023 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$6,111,537David S Stephens · Emory University · UM1 · FY2024 · AI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN
$6,110,413Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD
$6,107,805E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2025 · AG
Laboratory Animal Research Support & Model Development
$6,094,585Ruth Woodward · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers
$6,084,280Erica Ollmann Saphire · Scripps Research Institute, The · U19 · FY2017 · AI
Infectious Diseases Research Technologies Core - RML
$6,073,103Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2014 · AI
PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA (MVA) VACCINE
$6,072,797Harry Kleanthous · Sanofi Pasteur Biologics, Llc · N01 · FY2014 · AI